Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,437 total articles
Antalpha Platform Holding Company announced robust Q1 2026 results with 52% year-over-year revenue growth and enhanced profitability driven by its scalable digital asset platform. The acquisition of Aurelion contributed significantly, boosting adjusted EBITDA margin to 64%. The company is advancing its tokenized gold strategy to generate yield and …
Cullinan Therapeutics announced that the FDA has granted Orphan Drug Designation to CLN-049, a novel FLT3xCD3 T cell engager under investigation for treating relapsed/refractory acute myeloid leukemia (AML). The designation supports the drug's potential to address significant unmet medical needs in AML, including in patients with poor prognosis due…
Garrett Motion Inc. announced its 2026 Technology and Investor Day scheduled for May 20, 2026, where it will present updates on its Turbo, Zero-Emission Vehicle, and Industrial technology portfolios, alongside its long-term growth strategies and financial priorities. The event will include real-time and replay webcast access.
Korro Bio announced the selection of KRRO-111, a proprietary GalNAc-conjugated oligonucleotide therapeutic, as a development candidate for treating Alpha-1 Antitrypsin Deficiency (AATD). KRRO-111 leverages the company's OPERA RNA editing platform to correct the pathogenic mutation in the SERPINA1 gene, achieving over 90% editing efficiency and sign…
Lexeo Therapeutics, a clinical-stage genetic medicine company focused on cardiovascular diseases, announced its participation in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference. The live webcast will provide insights into their pipeline targeting genetic causes of heart conditions, featuring candidates like LX2006 and L…
Ambow Education Holding Ltd. (NYSE American: AMBO) has launched the HybriU Collaboration Board, an AI-powered phygital tool providing real-time collaborative whiteboard access via a single QR code. This innovation enables participants to interact with various content types without software installation or accounts, aiming to enhance hybrid collabor…
OKYO Pharma Limited appoints international expert Dr. Marta Sacchetti, MD, PhD, to its Scientific Advisory Board. This strategic addition strengthens the company's expertise in neuro-inflammatory corneal diseases, aligning with its development of urcosimod, a promising investigational therapy for neuropathic corneal pain (NCP). Having completed a s…
Osisko Development Corp. has appointed Greg Perrins as Vice President of Sustainable Development to enhance its approach to Indigenous relations and public sector engagement in British Columbia. Perrins brings over 15 years of experience in natural resource sectors and government roles, aiming to support the company’s flagship Cariboo Gold Project …
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced updated positive clinical data from its ongoing Expanded Access Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data showed intranasal foralumab was well tolerated with no new safety signals, demonstrated trends toward …
Quantum Cyber N.V. announced the filing of a provisional patent application with the USPTO for an autonomous naval mine countermeasure system designed to detect and neutralize underwater mines using unmanned aerial vehicles. The technology is timely and directly addresses a current military crisis in the Strait of Hormuz where Iran has deployed nav…
EyePoint, Inc., a clinical-stage biopharmaceutical company focused on innovative therapeutics for serious retinal diseases, announced its participation in several upcoming investor conferences including Stifel, Jefferies, and Goldman Sachs. The company highlighted its lead product candidate, DURAVYU™, a sustained delivery treatment undergoing Phase…
Orion Energy Systems announced preliminary unaudited results for fiscal year 2026, posting $86 million in revenue and adjusted EBITDA of at least $2 million, marking six consecutive quarters of positive adjusted EBITDA. The company reiterated fiscal year 2027 guidance with projected revenues between $95 million and $97 million and positive adjusted…
Tecnoglass, a leading producer of high-end aluminum and vinyl windows and architectural glass, announced attendance at three major investor conferences in May and June 2026. The company highlights its strong presence in the U.S. market, accounting for 95% of its revenues, and its significant manufacturing footprint in Colombia.
XORTX Therapeutics Inc., a clinical-stage pharmaceutical company specializing in therapies for gout and kidney diseases, has completed a $5 million public offering through issuing common shares and pre-funded warrants. The proceeds will support working capital, corporate purposes, and investor relations activities. The offering was made under an SE…
Vertex Inc. published a new global study highlighting growing revenue risks caused by misalignment among IT, Tax, and Finance teams in compliance processes. Despite strong ambitions for collaboration, many organizations suffer from governance gaps, poor data quality, and fragmented ownership, risking blocked transactions and delayed revenue. The re…
Fury Gold Mines Limited has initiated an extensive metallurgical testwork program at its 100% owned Eau Claire gold project in Quebec to support ongoing feasibility studies. The program aims to optimize ore processing, support tailings management, and ensure environmental compliance, paving the way for a detailed process flowsheet and development p…
Bowman Consulting Group Ltd. has been selected to lead the waterside design, permitting, and construction-phase services for the development of a cruise terminal facility at the Port of Philadelphia. This project is a key part of PhilaPort's $50 million capital initiative aimed at converting an existing wharf into a temporary terminal to accommodat…
Titan Machinery Inc. will release its financial results for the fiscal first quarter ended April 30, 2026 on June 9, 2026, with an accompanying investor conference call. The company operates full-service agricultural and construction equipment dealer locations across North America, Europe, and Australia, representing CNH Industrial brands.
Akamai Technologies introduces AI Brand Presence, a new solution designed to help businesses optimize their website content for AI search engines and autonomous agents. The platform translates content for large language models (LLMs), provides visibility into AI bot activity, and enhances brand presence in AI-generated results. Akamai's pilot showe…
Parsons Corporation announced the opening of Section 1 of the D Line Subway Extension in Los Angeles, marking completion of 3.9 miles of new subway track with three underground stations from Wilshire/Western to Beverly Hills. Parsons was the lead designer and managed the final design for this project segment, aimed at improving commuter access, red…
Hotel101 Global Holdings Corp., trading as HBNB on NASDAQ, reported that its 680-room Hotel101-Madrid property generated more than €100,000 in recurring room revenues in a single day at 100% occupancy. The Madrid hotel, serving as the company's global prototype, underscores strong demand and validates its asset-light, prop-tech hospitality model. T…
Natural Alternatives International, Inc. reported a net loss of $4.3 million for Q3 fiscal 2026 despite a 23% increase in net sales to $35.5 million driven by higher private-label contract manufacturing sales. The company continues to experience losses due primarily to underutilization of factory capacity. The firm secured a new $11 million term lo…
Shenandoah Telecommunications Company (Shentel) announced the completion of a $20 million broadband expansion project in Campbell County, Virginia, extending gigabit internet to more than 4,100 previously unserved homes. Funded partially through the Virginia Telecommunications Initiative and local contributions, the project enhances connectivity fo…
Relay Therapeutics announced initial Phase 2 clinical data from their ReInspire trial evaluating Zovegalisib, a selective PI3Kα inhibitor, in patients with PIK3CA-driven vascular anomalies. The data show a 60% volumetric response rate at 12 weeks with symptomatic improvements reported by both patients and investigators. The safety profile supports …
Bilibili Inc. announced its Q1 2026 financial results showing a 7% year-over-year increase in total net revenues to RMB7.47 billion (US$1.08 billion) and a net profit of RMB202 million compared to a net loss in Q1 2025. Key growth drivers include an 8% increase in daily active users to 115 million, 30% growth in advertising revenues aided by improv…
